BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News

Diabetes News Articles

Get Our Industry eNewsletter FREE email:    
 Top Breaking News
Thrasos Scores $21M to Complete Phase II THR-184, Expands Renal Portfolio     3/31/2015
EXCLUSIVE: Resverlogix Corporation (RVX.TO) CEO Says Experimental Cardiac Drug Holds High Hopes, As Biotech Booms     3/20/2015
AmerisourceBergen Corporation (ABC) the “Pony to Ride” for Biosimilar Opportunities, Says UBS     3/16/2015
Sanofi (SAN.PA) Wins FDA Approval for New Insulin Drug Toujeo     2/27/2015
Shares Surge as Novo Nordisk A/S (NVO) Shows Off Positive Trial Data for Oral Insulin     2/23/2015
Bayer AG (BAYZF) May Have a Buyer for Diabetes Biz     2/23/2015
Regeneron (REGN)'s Eylea Beats Genentech (RHHBY) in Rare Face Off Over Some Vision Loss Cases     2/20/2015
Pfizer (PFE) Failed in 2012 but Now Sanofi (SAN.PA) Will Take a Stab at a Fully Remote Diabetes Trial     2/12/2015
Stock Falls as Columnist Accuses Isis Pharmaceuticals, Inc. (ISIS) of Time-Shifting Diabetes Drug Trial to Embellish Data     2/4/2015
Eli Lilly (LLY), Adocia Ink $570 Million Pact To Develop Fast-Acting Insulin     12/19/2014
Analyst: Current Crop of Biotech IPOs a Mixed Bag of Low Market Caps, Little Data     12/3/2014
Bayer AG (BAYZF) Continues Efforts To Sell Diabetes Device Unit     11/25/2014
Best Value In Biotech? Actavis (ACT), Says UBS     11/17/2014
DiaMedica Inc. Announces Top-Line Results Of Phase 2a Clinical Trial Of DM199 For Type 2 Diabetes     11/17/2014
Servier Bets $1 Billion+ On Intarcia Therapeutics, Inc.'s Diabetes Device     11/13/2014
 Featured Stories
Why Drug For Type II Diabetes Makes People Fat, Georgia State University Study     3/27/2015
Metformin And Vitamin D3 May Prevent Colorectal Cancer, Case Western Reserve University Study     3/24/2015
Vitamin D May Prevent Diabetes, Clogged Arteries, Washington University in St. Louis Study     3/20/2015
How Artificial Light Can Mess With Your Health, University of Connecticut Researchers Say     3/20/2015
Fight Age-Related Diseases With Vitamin D, Loyola University Study Finds     3/18/2015
Viagra May Fight Diabetes, Henry Ford Health System Study     3/18/2015
Cough Medicine Ingredient May Aid Type 2 Diabetes Fight, Heinrich Heine University     3/18/2015
Mom's Age At Childbirth Tied To Son's Diabetes Risk, Ghent University Hospital Study     3/10/2015
Onions Could Lower Blood Sugar, Improve Cholesterol, Delta State University Study     3/10/2015
Losing 30 Minutes Of Sleep Per Day Tied To Weight Gain, Weill Cornell Medical College Study     3/10/2015
Hormone-Disrupting Chemicals "Cost Billions"     3/6/2015
First World War Explosive Could Reverse Diabetes, Yale University Study     3/2/2015
Benefit Of Exercise Magnified To Prevent Heart Condition, University of Virginia Reveals     2/25/2015
Lack Of Vitamin D Linked To Higher Diabetes Risk, Universidad de Málaga Study     2/24/2015
Diabetes, Depression Boost Dementia Risk, University College London Study     2/23/2015
 More News
PharmaCyte Biotech (NVLX) On Track to Commence Clinical Trials     3/27/2015
American Academy of Orthopaedic Surgeons Release: Diabetes, Previous Joint Pain And Overall Physical Health Predicts Arthritis Pain     3/24/2015
Cold Spring Harbor Laboratory And GlaxoSmithKline (GSK) To Develop Diabetes And Obesity Therapeutic     3/23/2015
Eli Lilly (LLY) Release: First-In-Class Type 2 Diabetes Treatment Glyxambi (empagliflozin/Linagliptin) Tablets For Adults Now Available In U.S. Pharmacies     3/23/2015
Intarcia Therapeutics, Inc. And Numab AG Sign Multi-Asset Collaboration To Develop Once-Yearly Therapies In Diabetes, Obesity, and Autoimmune Indications     3/20/2015
Award-Winning Actress S. Epatha Merkerson AndMerck & Co. (MRK) Challenge African Americans With Type 2 Diabetes To Get To Their Goals     3/20/2015
PharmaCyte Biotech (NVLX) Provides Update On Corporate Developments And Progress With Cancer And Diabetes Programs     3/16/2015
BioLineRx Ltd.’s Treatment for Type 1 Diabetes Effective In Preclinical Trials     3/11/2015
XOMA (US) LLC (XOMA) Presents Positive Phase I XOMA 358 Data At The ENDO Meeting     3/9/2015
American Diabetes Association Release: The Latest Tools for Living Well with Diabetes: Diabetes Forecast Magazine Publishes 2015 Consumer Guide     3/9/2015
Aerpio Announces Publication Of Positive Results Of Phase 1b/2a Clinical Trial Of Novel Tie2 Activator, AKB-9778, For The Treatment Of Patients With Diabetic Macular Edema (DME) – TIME-1 Study     3/4/2015
Sanofi (SAN.PA) Receives FDA Approval Of Once-Daily Basal Insulin Toujeo     2/26/2015
Novo Nordisk A/S (NVO) Announces Positive Results For Phase 2 Trial With Oral Semaglutide In People With Type 2 Diabetes     2/20/2015
Regeneron (REGN) Release: NIH-Sponsored Comparative Effectiveness Trial In Diabetic Macular Edema Shows EYLEA (Aflibercept) Injection Demonstrated Significantly Greater Gains In Visual Acuity Than Both Bevacizumab And Ranibizumab     2/19/2015
PharmaCyte Biotech Diabetes Consortium Member Publishes Review Article On Use Of Genetic Engineering To Treat Diabetes     2/13/2015